234 related articles for article (PubMed ID: 7059438)
21. The effect of antipyrine and rifampin on the metabolism of diazepam.
Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
[TBL] [Abstract][Full Text] [Related]
22. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
[TBL] [Abstract][Full Text] [Related]
23. Effect of single and multiple doses of sulphinpyrazone on antipyrine metabolism and urinary excretion of 6-beta-hydroxycortisol.
Staiger C; Schlicht F; Walter E; Gundert-Remy U; Hildebrandt R; de Vries J; Wang NS; Harenberg J; Weber E
Eur J Clin Pharmacol; 1983; 25(6):797-801. PubMed ID: 6141054
[TBL] [Abstract][Full Text] [Related]
24. Effect of spironolactone on antipyrine metabolism in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 Jul; 61(1):87-8. PubMed ID: 8819201
[TBL] [Abstract][Full Text] [Related]
25. Quinidine does not alter antipyrine metabolism.
Bowles SK; Cardozo L; Edwards DJ
J Clin Pharmacol; 1990 Mar; 30(3):267-71. PubMed ID: 2312782
[TBL] [Abstract][Full Text] [Related]
26. The effect of age and sex on metabolism and urinary excretion of antipyrine.
Jorquera F; Almar M; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
[TBL] [Abstract][Full Text] [Related]
27. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
28. Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group.
Uchino H; Inaba T; Kalow W
Xenobiotica; 1983 Mar; 13(3):155-62. PubMed ID: 6613161
[TBL] [Abstract][Full Text] [Related]
29. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
30. Influence of alaproclate on antipyrine metabolite formation in man.
Teunissen MW; Wahlén A; Vinnars E; Breimer DD
Eur J Clin Pharmacol; 1984; 27(4):447-52. PubMed ID: 6519152
[TBL] [Abstract][Full Text] [Related]
31. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
32. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains.
Buters JT; Reichen J
Biochem Pharmacol; 1990 Aug; 40(4):771-7. PubMed ID: 2386545
[TBL] [Abstract][Full Text] [Related]
33. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
[TBL] [Abstract][Full Text] [Related]
34. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
Villa JG; Bayon JE; González-Gallego J
J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
[TBL] [Abstract][Full Text] [Related]
35. Antipyrine clearance and metabolism in patients with psoriasis.
Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
[TBL] [Abstract][Full Text] [Related]
36. Effect of age on the pharmacokinetics of antipyrine in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
[TBL] [Abstract][Full Text] [Related]
37. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
38. Antipyrine metabolism is not affected by terbinafine, a new antifungal agent.
Seyffer R; Eichelbaum M; Jensen JC; Klotz U
Eur J Clin Pharmacol; 1989; 37(3):231-3. PubMed ID: 2612536
[TBL] [Abstract][Full Text] [Related]
39. Inhibition and induction of metronidazole and antipyrine metabolism.
Loft S; Sonne J; Poulsen HE; Petersen KT; Jørgensen BG; Døssing M
Eur J Clin Pharmacol; 1987; 32(1):35-41. PubMed ID: 3582467
[TBL] [Abstract][Full Text] [Related]
40. The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172.
De Boer A; Stiekema JC; Danhof M; Breimer DD
Br J Clin Pharmacol; 1991 Jul; 32(1):23-9. PubMed ID: 1716140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
